University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Chronic obstructive pulmonary disease hospital admissions and drugs—unexpected positive associations: a retrospective general practice cohort study

Harries, TH, Seed, P, Jones, S, Schofield, P and White, P (2014) Chronic obstructive pulmonary disease hospital admissions and drugs—unexpected positive associations: a retrospective general practice cohort study NPJ primary care respiratory medicine, 24.

[img] Text
Chronic obstructive pulmonary disease hospital admissions and drugs--unexpected positive associations: a retrospective general practice cohort study..pdf - ["content_typename_Accepted version (post-print)" not defined]
Restricted to Repository staff only
Available under License : See the attached licence file.

Download (512kB)
[img] PDF (licence)
SRI_deposit_agreement.pdf
Restricted to Repository staff only
Available under License : See the attached licence file.

Download (33kB)

Abstract

Background: Increased prescribing of inhaled long-acting anti-muscarinic (LAMA) and combined inhaled long-acting β2-agonist and corticosteroid (LABA+ICS) drugs for the treatment of chronic obstructive pulmonary disease (COPD) has led to hopes of reduced hospital admissions from this disease. Aims: To investigate the impact of rising primary care prescribing of LAMA and LABA+ICS drugs on COPD admissions. Methods: This retrospective cohort study of general practice COPD admission and prescribing data between 2007 and 2010 comprised a representative group of 806 English general practices (population 5,264,506). Outcome measures were practice rates of COPD patient admissions and prescription costs of LAMA and LABA+ICS. General practice characteristics were based on the UK quality and outcomes framework. Results: Rates of COPD admissions remained stable from 2001 to 2010. Practice-prescribing volumes of LAMA per practice patient and LABA+ICS per practice patient increased by 61 and 26%, respectively, between 2007 and 2010. Correlation between costs of LAMA and those of LABA+ICS increased year on year, and was the highest in 2010 (Pearson’s r=0.68; 95% confidence interval (CI), 0.64–0.72). Practice COPD admission rates were positively predicted by practice-prescribing volumes of LAMA (2010: B=1.23, 95% CI, 0.61–1.85) and of LABA+ICS (2010: B=0.32, 95% CI, 0.12–0.52) when controlling for practice list size, COPD prevalence and deprivation. Conclusion: The increase in the prescribing of LAMA and LABA+ICS inhalers was not associated with the predicted fall in hospital admission rates for COPD patients. The positive correlation between high practice COPD prescribing and high practice COPD admissions was not explained.

Item Type: Article
Authors :
AuthorsEmailORCID
Harries, THUNSPECIFIEDUNSPECIFIED
Seed, PUNSPECIFIEDUNSPECIFIED
Jones, SUNSPECIFIEDUNSPECIFIED
Schofield, PUNSPECIFIEDUNSPECIFIED
White, PUNSPECIFIEDUNSPECIFIED
Date : 20 May 2014
Identification Number : https://doi.org/10.1038/npjpcrm.2014.6
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 28 Mar 2017 10:57
Last Modified : 28 Mar 2017 10:57
URI: http://epubs.surrey.ac.uk/id/eprint/809345

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800